A Neuro-Technological Intervention for Adolescents With GAD
ConditionGeneralised Anxiety Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13-18
SponsorNational Healthcare Group, Singapore
About this trial
This study aims to evaluate the safety and acceptability of a basic neuro-technological intervention in the treatment of adolescents with Generalised Anxiety Disorder (GAD). Our technology will deliver a mindfulness-based anxiety regulation intervention through a neuro- / bio-feedback-based virtual reality (VR) game interface that is driven by a novel algorithm.
Eligibility criteria
Qualifiers
Between 13 to 18 years of age inclusive
Literate in English Language
Newly diagnosed with Generalised Anxiety Disorder: current episode, based on Computerised Diagnostic Interview Schedule for Children (C-DISC)
If on medication, dosage stable or unchanged for at least preceding 8 weeks
Disqualifiers
Diagnosis (as defined by DSM-5) of: anxiety disorder induced by medication, substance, or another medical condition; obsessive compulsive disorder; bipolar disorder; any psychotic disorder (lifetime); intellectual disability (i.e. IQ<70); autism spectrum disorder; attention-deficit/hyperactivity disorder
History of substance or drug use disorder (as per DSM-5 criteria) within the last 3 months
Neurological disorders or insults (e.g. epilepsy, cerebrovascular accidents)
Metal in the cranium, skull defects, or skin lesions on scalp (e.g. cuts, abrasion, rash) at proposed electrode sites
Trial design
Treatments tested in this trial
- Neuro-technological Intervention
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
National Healthcare Group, Singapore
Lead sponsor
Duke-NUS Graduate Medical School
Collaborator
Singapore General Hospital
Collaborator
Nanyang Technological University
Collaborator
Source ClinicalTrials.gov